Affordable Access

deepdyve-link deepdyve-link
Publisher Website

A method to identify and validate mitochondrial modulators using mammalian cells and the worm C. elegans.

Authors
  • Andreux, Pénélope A
  • Mouchiroud, Laurent
  • Wang, Xu
  • Jovaisaite, Virginija
  • Mottis, Adrienne
  • Bichet, Sabrina
  • Moullan, Norman
  • Houtkooper, Riekelt H
  • Auwerx, Johan
Type
Published Article
Journal
Scientific Reports
Publisher
Springer Nature
Publication Date
Jan 01, 2014
Volume
4
Pages
5285–5285
Identifiers
DOI: 10.1038/srep05285
PMID: 24923838
Source
Medline
License
Unknown

Abstract

Mitochondria are semi-autonomous organelles regulated by a complex network of proteins that are vital for many cellular functions. Because mitochondrial modulators can impact many aspects of cellular homeostasis, their identification and validation has proven challenging. It requires the measurement of multiple parameters in parallel to understand the exact nature of the changes induced by such compounds. We developed a platform of assays scoring for mitochondrial function in two complementary models systems, mammalian cells and C. elegans. We first optimized cell culture conditions and established the mitochondrial signature of 1,200 FDA-approved drugs in liver cells. Using cell-based and C. elegans assays, we further defined the metabolic effects of two pharmacological classes that emerged from our hit list, i.e. imidazoles and statins. We found that these two drug classes affect respiration through different and cholesterol-independent mechanisms in both models. Our screening strategy enabled us to unequivocally identify compounds that have toxic or beneficial effects on mitochondrial activity. Furthermore, the cross-species approach provided novel mechanistic insight and allowed early validation of hits that act on mitochondrial function.

Report this publication

Statistics

Seen <100 times